Silexion Therapeutics Ltd. (SLXN)
$0.21-8.70%Close
BUYCRISIS · day 13
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $87,989
- Beta
- -0.25
- P/E (TTM)
- -0.00
- Short % float
- 1188.06%
- Days to cover
- 1.0
- SI change
- +1964.4%
- 1W
- -19.23%
- 1M
- -50.00%
- vs SPY 1W
- -20.39%
- vs SPY 1M
- -52.99%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on SLXN?
- LOPJLB’s latest quantitative signal on Silexion Therapeutics Ltd. (SLXN) is BUY in a CRISIS regime. Signals are updated daily.
- What market regime is SLXN in?
- Silexion Therapeutics Ltd. (SLXN) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Silexion Therapeutics Ltd. (SLXN) do?
- Silexion Therapeutics LTD is a biopharmaceutical company specializing in the discovery and advancement of RNA interference (RNAi)-based cancer therapies and their associated delivery systems, with a focus on treating aggressive solid tumors. The company's strategy for addressing these tumors relies on its proprietary LODER delivery platform. Its product pipeline features several key candidates:…